December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
UVEITIS AND HLA-B27 : Prospective Study of 175 Cases
Author Affiliations & Notes
  • D Monnet
    Ophthalmology
    Cochin University Hospital Paris France
  • M Breban
    Rheumatology
    Cochin University Hospital Paris France
  • C Hudry
    Rheumatology
    Cochin University Hospital Paris France
  • M Dougados
    Rheumatology
    Cochin University Hospital Paris France
  • AP BREZIN
    Ophthalmology
    Cochin University Hospital Paris France
  • Footnotes
    Commercial Relationships   D. Monnet, None; M. Breban, None; C. Hudry, None; M. Dougados, None; A.P. Brezin, None. Grant Identification: none
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4252. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D Monnet, M Breban, C Hudry, M Dougados, AP BREZIN; UVEITIS AND HLA-B27 : Prospective Study of 175 Cases . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4252.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To assess the systemic manifestations associated with HLA-B27 uveitis. To analyze the characteristics of ocular inflammation. Methods: Monocentric, prospective study of 175 patients seen between January 1996 and March 2001 with acute anterior uveitis and HLA-B27 allele. Patients were systematically referred for a rheumatologic evaluation and diagnosis were based on criteria from the European Spondylarthropathy Study Group. Results: There were 99 males and 76 females. The mean age was 40.4 ± 13.3 years at the time of the study and 34.5 ± 13.9 years at the time of the first episode of uveitis. The average time between the first episode of uveitis and the last visit during the study period was 7.5 ± 7.2 years (median : 5.1). The mean number of episodes of uveitis since the onset of the disease was 4.9 ± 7.9 (median : 3). The mean frequency of recurrences was 0.8 ± 0.6 per year. Posterior segment involvement was observed in 45 (25.7%) patients. Final visual acuity was unchanged in 125 (71%) cases. A systemic disease was present in 136 (77.7%) cases, which was diagnosed on the occasion of the uveitis in 88 (64.7%) cases. Ankylosing spondylitis was the most frequent associated disease, presumed in 17 (9.7%) cases and definite in 81 (46.3%) cases. Other forms of spondylarthropathies were diagnosed in 29 (17%) cases. Reactive arthritis (6 cases), psoriasic rheumatism (2 cases) and isolated Crohn’s disease (1 case) were also observed. The mean delay between the first systemic manifestations and the first episode of uveitis was 7.6 10.5 years (range -6.0 to 56.1 years). No age difference at the time of the study were observed in patients with or without systemic disease : respectively 40.5 ± 12.3 and 39.8 ± 16.4 years (p=0.81). However, patients with associated systemic diseases had a greater total number of recurrences than patients with uveitis only : respective average 5.4 ± 8.8 and 3.1 ± 3.3 (p=0.016). Conclusion: The visual prognosis of B27 uveitis was favorable in most cases. Uveitis was frequently a manifestation leading to a previously undiagnosed spondylarthropathy.

Keywords: 437 inflammation • 353 clinical (human) or epidemiologic studies: outcomes/complications • 612 uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×